Filter By Category
Archives
Share on -
AVIPTADIL
Generic Name: AVIPTADIL
ABSTRACT -
Aviptadil is a synthetic vasoactive intestinal peptide (VIP) analog with vasodilatory and immunomodulatory activity studied for pulmonary and inflammatory conditions. It is a peptide and does not have a practical single small-molecule skeletal drawing in this document. The representation above is a peptide schematic.
This document is for structured API information only. It is not a prescribing guide. Clinical use, if any, must follow the approved local label, trial protocol, and specialist medical supervision.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- No approved public dosing regimen is established for routine clinical use unless specifically authorized in a local label.
- Clinical-study dosing, when applicable, is protocol-specific and must not be copied into routine practice.
- Do not administer outside an authorized clinical trial, compassionate-use pathway, or approved product labeling.
SIDE EFFECTS-
Possible side effects and safety concerns include:
- Flushing, headache, dizziness, low blood pressure, or tachycardia
- Nausea, diarrhea, abdominal discomfort, or dry mouth
- Injection or infusion-site reactions depending on formulation
- Respiratory symptoms may fluctuate in the underlying disease being treated
- Serious hypersensitivity reactions are possible
ALLERGIC REACTIONS -
Hypersensitivity to Aviptadil or related compounds/products may occur. Symptoms may include:
- Immediate urticaria, itching, flushing, or generalized rash
- Facial, lip, tongue, or throat swelling
- Wheezing, chest tightness, or breathing difficulty
- Dizziness, fainting, severe hypotension, or collapse
- Anaphylaxis, although uncommon, requires emergency medical treatment
Important: Patients who develop an allergic reaction to Aviptadil should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS-
Aviptadil may interact with certain medicines, biologics, vaccines, protocols, or clinical conditions. Caution is needed with:
- Antihypertensives, nitrates, PDE5 inhibitors, or vasodilators may increase hypotension risk.
- Other pulmonary vasodilators require specialist coordination.
- Critical-care medicines can complicate hemodynamic monitoring.
- Patients should report all medicines, supplements, and inhaled therapies.
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Monitor blood pressure, heart rate, and respiratory status during administration.
- Use caution in unstable cardiovascular disease or severe hypotension.
- Do not use as a substitute for emergency respiratory care.
- Pregnancy and lactation safety are not established unless specifically studied.
WARNINGS –
- Investigational status: safety and effectiveness for routine use may not be established.
- Serious or unexpected adverse events must be managed under protocol and reported promptly.
- Use only by personnel trained for the relevant formulation and administration route.
- Keep out of reach of children.
Share on -
. Developed by